Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2010 | 1 |
2011 | 5 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors.
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4467-70. doi: 10.1016/j.bmcl.2009.05.029. Epub 2009 May 13.
Bioorg Med Chem Lett. 2009.
PMID: 19553108
Free PMC article.
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.
Deng X, Dzamko N, Prescott A, Davies P, Liu Q, Yang Q, Lee JD, Patricelli MP, Nomanbhoy TK, Alessi DR, Gray NS.
Deng X, et al.
Nat Chem Biol. 2011 Apr;7(4):203-5. doi: 10.1038/nchembio.538. Epub 2011 Mar 6.
Nat Chem Biol. 2011.
PMID: 21378983
Free PMC article.
Item in Clipboard
In situ kinase profiling reveals functionally relevant properties of native kinases.
Patricelli MP, Nomanbhoy TK, Wu J, Brown H, Zhou D, Zhang J, Jagannathan S, Aban A, Okerberg E, Herring C, Nordin B, Weissig H, Yang Q, Lee JD, Gray NS, Kozarich JW.
Patricelli MP, et al.
Chem Biol. 2011 Jun 24;18(6):699-710. doi: 10.1016/j.chembiol.2011.04.011.
Chem Biol. 2011.
PMID: 21700206
Free PMC article.
Item in Clipboard
High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.
Miduturu CV, Deng X, Kwiatkowski N, Yang W, Brault L, Filippakopoulos P, Chung E, Yang Q, Schwaller J, Knapp S, King RW, Lee JD, Herrgard S, Zarrinkar P, Gray NS.
Miduturu CV, et al.
Chem Biol. 2011 Jul 29;18(7):868-79. doi: 10.1016/j.chembiol.2011.05.010.
Chem Biol. 2011.
PMID: 21802008
Free PMC article.
Item in Clipboard
Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer.
Liu Q, Wang J, Kang SA, Thoreen CC, Hur W, Ahmed T, Sabatini DM, Gray NS.
Liu Q, et al.
J Med Chem. 2011 Mar 10;54(5):1473-80. doi: 10.1021/jm101520v. Epub 2011 Feb 15.
J Med Chem. 2011.
PMID: 21322566
Free PMC article.
Item in Clipboard
Discovery of selective irreversible inhibitors for EGFR-T790M.
Zhou W, Ercan D, Jänne PA, Gray NS.
Zhou W, et al.
Bioorg Med Chem Lett. 2011 Jan 15;21(2):638-43. doi: 10.1016/j.bmcl.2010.12.036. Epub 2010 Dec 10.
Bioorg Med Chem Lett. 2011.
PMID: 21208802
Free PMC article.
Item in Clipboard
Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase.
Hur W, Velentza A, Kim S, Flatauer L, Jiang X, Valente D, Mason DE, Suzuki M, Larson B, Zhang J, Zagorska A, Didonato M, Nagle A, Warmuth M, Balk SP, Peters EC, Gray NS.
Hur W, et al.
Bioorg Med Chem Lett. 2008 Nov 15;18(22):5916-9. doi: 10.1016/j.bmcl.2008.07.062. Epub 2008 Jul 18.
Bioorg Med Chem Lett. 2008.
PMID: 18667312
Free PMC article.
Item in Clipboard
Cite
Cite